Literature DB >> 18997095

Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.

Christina M Warboys1, Hong-Boon Toh, Paul A Fraser.   

Abstract

PURPOSE: The accumulation of advanced glycation end products (AGEs) within the retina in diabetes is associated with a chronic increase in retinal microvascular permeability. Isolated perfused retinas were used to examine the acute effects of AGEs on retinal microvascular permeability.
METHODS: Retinas were dissected from eyes obtained from male Wistar rats, pinned out flat, and perfused with the low-molecular-weight fluorescent dye sulforhodamine B. Microvascular permeability was determined from the rate of decrease in fluorescence gradient across a vessel under conditions of zero flow. The production of reactive oxygen species (ROS) in JG2.1 retinal endothelial cells was also assessed with a fluorescent probe working solution.
RESULTS: A 30-second application of AGE-modified bovine serum albumin (AGE-BSA) to the abluminal surface of the retinal vasculature produced a rapid dose-dependent increase in retinal capillary permeability that was inhibited by pretreatment with anti-RAGE IgG. The permeability response also required ROS generated by NADPH oxidase because pretreatment with apocynin and the free radical scavengers superoxide dismutase and catalase significantly reduced the response. Pretreatment with calphostin C, SKF-96365, and U-73122 also significantly reduced the permeability response. In addition, the permeability response to bradykinin increased permeability through ROS and was potentiated after pretreatment with AGE-BSA. This potentiation was blocked by apocynin.
CONCLUSIONS: Acute activation of NADPH oxidase by phospholipase C-mediated activation of Ca(2+)-dependent PKC occurs downstream of RAGE activation to acutely increase retinal capillary permeability in the isolated perfused rat retina.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18997095     DOI: 10.1167/iovs.08-2730

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Ascorbic acid prevents high glucose-induced apoptosis in human brain pericytes.

Authors:  James M May; Ashwath Jayagopal; Zhi-Chao Qu; William H Parker
Journal:  Biochem Biophys Res Commun       Date:  2014-08-22       Impact factor: 3.575

2.  Intracellular ascorbate tightens the endothelial permeability barrier through Epac1 and the tubulin cytoskeleton.

Authors:  William H Parker; Elizabeth Meredith Rhea; Zhi-Chao Qu; Morgan R Hecker; James M May
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-07       Impact factor: 4.249

3.  Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction.

Authors:  Yan-Min Long; Xing-Chen Zhao; Allen C Clermont; Qun-Fang Zhou; Qian Liu; Edward P Feener; Bing Yan; Gui-Bin Jiang
Journal:  Nanotoxicology       Date:  2015-09-23       Impact factor: 5.913

Review 4.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

Review 5.  Ascorbic acid repletion: A possible therapy for diabetic macular edema?

Authors:  James M May
Journal:  Free Radic Biol Med       Date:  2016-02-17       Impact factor: 7.376

Review 6.  Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation.

Authors:  Shi Fang Yan; Shi Du Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

7.  Ascorbate reverses high glucose- and RAGE-induced leak of the endothelial permeability barrier.

Authors:  M Elizabeth Meredith; Zhi-Chao Qu; James M May
Journal:  Biochem Biophys Res Commun       Date:  2014-01-25       Impact factor: 3.575

8.  C-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction.

Authors:  Mohammad Dahrouj; Oday Alsarraf; Yueying Liu; Craig E Crosson; Zsolt Ablonczy
Journal:  J Pharmacol Exp Ther       Date:  2012-10-19       Impact factor: 4.030

Review 9.  The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.

Authors:  Ravichandran Ramasamy; Alexander Shekhtman; Ann Marie Schmidt
Journal:  Expert Opin Ther Targets       Date:  2015-11-11       Impact factor: 6.902

Review 10.  AGE-RAGE synergy influences programmed cell death signaling to promote cancer.

Authors:  Bhargav N Waghela; Foram U Vaidya; Kishu Ranjan; Abu Sufiyan Chhipa; Budhi Sagar Tiwari; Chandramani Pathak
Journal:  Mol Cell Biochem       Date:  2020-10-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.